Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.

Volume: 71, Issue: 6, Pages: 1164 - 1174
Published: Aug 14, 2019
Abstract
Background & Aims null Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma (HCC). We aimed to compare the efficacy and safety of a combination of sorafenib and selective internal radiation therapy (SIRT) – with yttrium-90 (90Y) resin microspheres – to sorafenib alone in patients with advanced HCC. null null null Methods null SORAMIC is a randomised controlled trial comprising diagnostic, local ablation and...
Paper Details
Title
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
Published Date
Aug 14, 2019
Volume
71
Issue
6
Pages
1164 - 1174
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.